Áö¿¥ÇǾÆÀÌ´Â ´ëÇѹα¹ Á¦¾à¾÷°èÀÇ GMP Think-Tank¸¦ Ãß±¸ÇÕ´Ï´Ù.

       gmpeye

¡« home ¡« gmp guides & guidelines ¡« specialty services ¡«

GMP ±³À° / ÄÁ¼³Æà / GMP ¹®¼­ ¹ø¿ª

US FDA CGMP

US FDA guidelines

EU GMP guides

EMA Q-guidelines

ICH API GMP

ICH Q/M(CTD)

WHO GMP

CGMP Q&A

Industry Issues: Contamination Control Strategy, Data Integrity, QbD

e-newsletter

Korean GMP

 

 

GMP Case Study: Lessons from FDA 483s & Warning Letters

 

 


ICH API GMP

 

ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

1

Introduction

2

Quality Management

3

Personnel

4

Buildings and Facilities

5

Process Equipment

6

Documentation and Records

7

Materials Management

8

Production and In-Process Controls

9

Packaging and Identification Labelling of APIs and Intermediates

10

Storage and Distribution

11

Laboratory Controls

12

Validation

13

Change Control

14

Rejection and Re-use of Materials

15

Complaints and Recalls

16

Contract Manufactures (including Laboratories)

17

Agents, Brokers, Traders, Distributors, Repackers, and Relabellers

18

Specific Guidance for APIs Manufactured by Cell Culture/Fermentation

19

APIs for Use in Clinical Trials

20

Glossary

 

 

 

ICH Q7 Implementation Working Group - ICH Q7 Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients: Questions & Answers

 


 

gmpeyelogo.gif

Copyright ¨Ï gmpeye. Since 2005. All rights reserved.